NEWARK, Del, June 26, 2024 (GLOBE NEWSWIRE) -- The IV therapy and vein access devices market is expected to reach USD 28.7 billion by 2024. From 2024 to 2034, revenue is expected to increase by 5.1% ...

This report provides an in-depth analysis of the global IV therapy and venous access market, covering applications across various healthcare settings. It studies IV solutions, infusion pumps and ...

A simple reversal of the way a long-standing surgical procedure is performed to create an arteriovenous fistula for hemodialysis access significantly improves the fistula's function and longevity over ...

Axillary vein access has emerged as a safe and efficient alternative for cardiac device implantation. By utilising the anatomical course of the axillary vein, clinicians can facilitate the insertion ...

Argon Medical Devices — a manufacturer of medical device solutions for interventional radiology, vascular surgery, interventional cardiology, and oncology — recently introduced its Traveler Portal ...

In our practice, a commitment to autologous access began even before the publication of the DOQI guidelines. Early in our experience, prosthetic grafts were generally the third line of intervention ...

ALTON, Ill. — A local registered nurse is gaining worldwide recognition for pioneering a phlebotomy technique that makes getting stuck with a needle less painful and troublesome for patients. Working ...

The global IV therapy and vein access devices market is on a trajectory of significant growth, projected to expand from USD 28.7 billion in 2024 to an estimated USD 47.3 billion by 2034. With a ...

Anviz, a brand of Xthings, a global pioneer in intelligent security solutions, announces the upcoming release of its latest access control solution, the M7 Palm, equipped with cutting-edge Palm Vein ...

The MarketWatch News Department was not involved in the creation of this content. "Intravenous (IV) therapy and vein access play a crucial role in delivering medications, fluids and nutrients directly ...